Evidence map›Paper›PMID 42576716›Full record

ArticleJournal of Korean medical science2026

Vaccine Handling Management in Korea, Japan, and Taiwan: A Comparative Study of Storage Standards, Implementation Practices, and Regulatory Approaches.

Cho Ryok Kang, Ji Yun Noh, Won Suk Choi, Young June Choe, Hajime Kamiya, Seiichi Tomotaki, Hiroko Tomotaki, Li-Min Huang, Sumyeong Choe, Young Hwa Lee and 4 more

Abstract readComparative Study
In one paragraph

Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Cho Ryok Kang *Department of Nursing, Wonkwang University, Iksan, Korea.ORCID https://orcid.org/0000-0002-9212-8292
Ji Yun Noh *Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8541-5704
Won Suk ChoiDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3253-4827
Young June ChoeAllergy and Immunology Center, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-2733-0715
Hajime KamiyaDepartment of Public Health, Occupational Medicine, and Applied Epidemiology, Graduate School of Medicine, Mie University, Tsu, Japan.ORCID https://orcid.org/0000-0003-3698-9044
Seiichi TomotakiDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-7004-6608
Hiroko TomotakiDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0001-7342-3635
Li-Min HuangDepartment of Pediatrics, National Taiwan University Children's Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-9291-260X
Sumyeong ChoeAllergy and Immunology Center, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0009-0000-2299-7719
Young Hwa LeeAllergy and Immunology Center, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-2073-993X
Nam-Kyong ChoiDepartment of Health Convergence, Ewha Womans University, Seoul, Korea.ORCID https://orcid.org/0000-0003-1153-9928
Heehyun WonDepartment of Health Convergence, Ewha Womans University, Seoul, Korea.ORCID https://orcid.org/0000-0001-9601-3786
Suyeon JeongDivision of Vaccine Supply, Korea Disease Control and Prevention Agency, Cheongju, Korea.ORCID https://orcid.org/0000-0002-1207-9487
Jong-Koo LeeNational Academy of Medicine of Korea, Seoul, Korea. kcdc7000@gmail.com.ORCID https://orcid.org/0000-0003-4833-1178

Funding

Korea Disease Control and Prevention AgencyNational Academy of Medicine of Korea
6 · The paper itself

Abstract

backgroundRobust vaccine cold-chain management safeguards potency and public trust. Korea, Japan, and Taiwan share core practices (2-8°C storage, continuous monitoring, first-expiry-first-out [FEFO] stock rotation) yet differ in implementation and governance. We compared standards and real-world practices across the three systems to identify actionable improvements for Korea.

methodsFrom March-July 2025 we conducted structured interviews and onsite observations at public health centers, hospitals, and clinics in Korea, Taiwan (National Taiwan University Children's Hospital), and Japan (Kyoto University Hospital, Katsura Hospital, and multiple Osaka/Mie sites). We reviewed the latest national guidance and synthesized findings across four domains: 1) storage facilities/equipment, 2) temperature monitoring and excursion response, 3) inventory management/disposal, and 4) governance/compliance.

resultsAll three countries uphold core cold-chain principles, but system design varies. Taiwan applies centrally coordinated, de facto mandatory standards: government-supported data loggers with alarms, immediate excursion reporting, regular checklist-based inspections, regional backup storage, and a differentiated wastage policy (reimbursement for unavoidable loss; penalties for preventable waste). Japan employs a trust-based, decentralized model, where the widespread use of purpose-built refrigerators and continuous monitoring is common practice rather than a national legal mandate. This system is governed by professional norms, provider-borne financial liability for waste, provider-led excursion decisions (discarding if viability is uncertain), and local-level stock redistribution networks. Korea's evolving hybrid model provides detailed technical guidance (since 2021), promotes automated monitoring and FEFO, and encourages contingency planning; however, requirements are largely advisory, inspections are ad hoc, and formal redistribution and incident-reporting systems remain under development. Comparative tables highlight stricter equipment mandates and enforcement in Taiwan, Japan's reliance on professional norms and financial incentives, and Korea's partial implementation gap.

conclusionTo strengthen reliability and reduce waste, Korea could 1) confer regulatory status on key standards, 2) institute routine audits and incident reporting, 3) formalize regional backup/storage networks, 4) enable systematic stock redistribution, and 5) align incentives with a differentiated compensation scheme. Drawing on Taiwan's enforcement/support model and Japan's local-level redistribution networks can help Korea achieve uniformly high performance while maintaining operational feasibility.

Indexed as

Drug StorageRefrigerationVaccinesHumansJapanRepublic of KoreaTaiwanVaccinesCold ChainDrug StorageJapanKoreaQuality ControlTaiwanTemperatureVaccines

Identifiers

PMID42576716
PMCPMC13457786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.